LSC Webinars CELL All
-
Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing
6/2/2026
See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.
-
Challenges And Opportunities With Novel AAV Capsids
6/2/2026
Explore challenges and solutions in developing novel AAV capsids, focusing on manufacturing complexity, analytical testing, and regulatory considerations for advancing gene therapy effectiveness.
-
CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic
5/29/2026
As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.
-
Quality By Design: The Future Of Automated Pharmaceutical Labeling
5/28/2026
Learn how applying Quality by Design principles to automated labeling platforms utilizes robotics to eliminate manual errors and seamlessly adapt to future pharmaceutical packaging formats.
-
In Vivo CAR-T And Gene Editing: Manufacturing Reality Behind The Promise
5/27/2026
Gain practical insights into the manufacturing realities shaping in vivo CAR-T development and learn how leading teams are addressing the challenges of scaling both LNP and viral vector platforms."
-
Real-Time DAR And Concentration Measurement Without Dilution
5/27/2026
Maintaining consistent DAR while reducing risk and variability remains a major ADC challenge. Learn how real‑time spectroscopy replaces dilution‑heavy workflows and strengthens process control.
-
Advancing Therapeutic Discovery With High-Throughput Electroporation
5/21/2026
Learn how high-throughput electroporation streamlines genetic material delivery for cell therapy and drug discovery, offering speed, precision, and scalability across hard-to-transfect cell types.
-
The Framework For Containment In A Cleanroom
5/20/2026
ISO classification decisions shape cleanroom design. Learn how early alignment between process needs, biosafety, and classification can reduce redesign risk while supporting scalable environments.
-
Understanding The Regulatory Landscape For Ophthalmic Drug Products
5/14/2026
Learn how evolving ophthalmic regulations, contamination control strategies, and advanced packaging solutions can help support compliance, product quality, and patient safety.
-
AI Meets Informed Consent: Opportunity, Risk, and What IRBs Need to See
5/14/2026
Expert perspectives on IRB oversight, health literacy, and research ethics offer practical guidance to strengthen consent, protect participants, and align compliance with real-world research.